Let's Talk Contemporary Surgery for Primary Mitral Regurgitation

Let's Talk, Contemporary Surgery for Primary Mitral Regurgitation

Originally Broadcast: Thursday, September 23, 2021 at 7:00 PM ET

Join us for a case-based discussion with well-known MIS Mitral Valve Surgeons as they discuss considerations for mitral valve repair and replacement based on disease pathology, patient age, guidelines, and clinical trial advancements.

Mario Castillo-Sang, M.D.
St. Elizabeth Healthcare
Edgewood, KY

Gorav Ailawadi, M.D.
University of Michigan
Ann Arbor, MI

Marc Gerdisch, M.D.
Franciscan Health
Indianapolis, IN

Rochus K. Voeller, M.D.
University of Minnesota
Minneapolis, MN



The views expressed during this presentation are the speaker’s own and do not necessarily reflect those of CryoLife, the speaker’s employer, organization, committee or other group or individual.  Unattributed data, device selection, and procedural guidance is a matter of physician preference are presented on the basis of the individual speaker’s observations and experiences and should be treated accordingly. Federal law restricts the devices discussed herein to sale by or on the order of a physician. Refer to the Instructions for Use and other product insert documentation that accompanies each of these devices for indications, contraindications, warnings, precautions, possible complications, and instructions for use.  

On-X® Prosthetic Heart Valves IFU’s

Products not available in all markets.  The content of this presentation, including any copyrightable content included herein, is used with permission from the speaker.

On-X Life Technologies, Inc. is a wholly owned subsidiary of CryoLife, Inc. The On-X® Prosthetic Heart Valves are manufactured by On-X Life Technologies, Inc. The snowflake design, CryoLife, Life Restoring Technologies, and On-X are registered trademarks owned by CryoLife, Inc. or its subsidiaries. All other registered trademarks are owned by their respective owners. © 2021 CryoLife, Inc. All rights reserved.

Created by